Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia Olga Sanchez-Pernaute; Fredeswinda I. Romero-Bueno; Albert Selva-O¿Callaghan;

Therapeutic options for the management of severe COVID-19: A rheumatology perspective Claudia Mendoza-Pinto; Mario García-Carrasco; Pamela Munguía Realpozo; Socorro Méndez-Martínez;